COVAX

UNICEF's Access to COVID-19 Tools Accelerator Supplies Financing Facility (ACT-A SFF) is a UNICEF-housed fund dedicated to supporting low- and middle-income countries through access to access key COVID-19 supplies via the organization’s Procurement Services. Find below a geographic overview, overall funding status, and quarterly public reports…, Quarterly reports, To learn more about ACT-A SFF or UNICEF's ongoing global response to COVID-19:

Contributions received by the facility, supply transactions and country-level list of supplies financed with contributions to the ACT-A SFF as of 31 December 2023.

The largest vaccine supply operation ever began in February 2021 – and UNICEF is leading it on behalf of  COVAX . Our goal is to ensure that all countries and territories participating in COVAX have equitable access to COVID-19 vaccines. As of 15 November 2022, COVAX has delivered 1.8 billion vaccines to 146 countries.  , How?, Through COVAX – led by Gavi, the Vaccine Alliance , WHO and CEPI – UNICEF is working with manufacturers and partners on the procurement of COVID-19 vaccine doses, as well as freight, logistics, storage and rollout in countries. In collaboration with the PAHO Revolving Fund, we are leading the procurement and delivery for low and middle-income…, When did COVAX begin?, UNICEF has been organizing the international transport of COVID-19 vaccines for COVAX since February 2021. COVAX continues to deliver vaccines to countries and territories around the world, with the aim of protecting frontline health care and social workers, as well as high-risk and vulnerable groups. You can find out more about upcoming…, Why UNICEF?, As the largest single vaccine buyer in the world, UNICEF has a unique and longstanding expertise in procurement and logistics to help children in need.  UNICEF procures more than 2 billion doses of vaccines annually for routine immunization and outbreak response on behalf of nearly 100 countries. We are the main procurement partner of Gavi, the…, COVID-19 Vaccine Market Dashboard, Up-to-date information on the distribution and market developments of COVID-19 vaccines. Screenshot of UNICEF's COVID-19 Vaccine Market Dashboard Screenshot taken on 15 November 2022., Latest updates and stories, Featured video, Thank you to our high value private sector partners and public partners for the important role they played in UNICEF’s response to the COVID-19 pandemic., Meet our experts, We are working to make COVID-19 vaccines available for delivery. Meet some of the people who are behind this gigantic and complex operation., To understand the historic task of procuring and delivering COVID-19 vaccines, COVAX and partners logos

The COVID-19 pandemic has demonstrated the clear need for the world to be better prepared the next time a public health emergency of this scale strikes. Rapid and equitable global access to medical interventions, such as therapeutics, diagnostics, and in particular vaccines, which offer the best line of defense for vaccine preventable diseases,…

COVAX has access to enough COVID-19 vaccines to help protect 70% of the population in 91 lower-income countries Demand and uptake are low, with low-income countries remaining furthest behind To close the global vaccine equity gap, COVAX calls on countries to set ambitious targets for implementation and on all partners to ensure countries have the…, Demand and delivery, With more than 3.8 billion COVID-19 doses administered to-date, national governments in lower-income countries have led the way. The number of countries with coverage under 10% of the population has decreased from 34 in January to 18 today. Some AMC-supported countries – for example, Bhutan, Cambodia, Viet Nam, Maldives, Fiji and Bangladesh – have…, Supply, It is testament to the ground-breaking work of the scientific and manufacturing communities that there is now enough global supply to meet needs, as is the fact that it took only 327 days to go from the SARS-CoV-2 virus being sequenced and published to bringing a COVID-19 vaccine into emergency use. As we strive to help countries deploy more doses…

COVAX aspires to enable equitable, full vaccination of all adult and adolescent populations globally to reduce the impact of the ongoing pandemic, allow economies and societies to function, and guard against the future evolution of the virus. Updated April 2022.

In-country logistics coordination paving the way for vaccine deployment  , In 2021, the COVAX Facility, the global mechanism for equitable access to COVID-19 vaccines, delivered COVID-19 Vaccine Market Dashboard over 958 million vaccine doses to 144 countries and territories with support from UNICEF as the procurement, delivery and lead programme implementation agency. This achievement has been made possible through in-…, Advancing coverage commitments and best practices in Nepal, Uzbekistan and Mozambique , The National Committee for Vaccine and Cold Chain Management (NCVCCM), an equivalent of the NLWGs in Nepal, convenes partners to forecast needs and develop supply plans for the procurement of vaccines and ancillary supplies. This committee is led by the Ministry of Health and Population (MOHP) and the Expanded Programme on Immunization (EPI) with…, Addressing inequity challenges, Having the right infrastructure, tools and processes will further drive efforts to successfully rollout COVID-19 vaccines to communities. The complexity of in-country rollout, particularly in low-income countries and fragile contexts, requires contextualized supply and logistics solutions which the NLWG should implement with partners. Coordinated…

Around 50 participants, including suppliers and UNICEF and GAVI representatives attended the What is a cold chain? Cold Chain Equipment Industry Consultation in March 2022. The meeting discussed the upcoming bidding exercises focused on solar direct drive refrigerators and freezers (SDD) and mains-powered ice lined refrigerators and freezers (ILR…,   Welcome and introduction Thomas Sorensen, UNICEF Supply Division (SD) 2021 Procurement figures and 2022 outlook Jan Komrska, SD Spare parts tender •    Technical considerations •    Commercial consideration Teshome Yemamu, SD Jan Komrska, SD SDD/ILR Tender outcomes •    Tender objectives and outcomes •    Technical issues •    Firm contractin…, UNICEF/UNI197921/Schermbrucker Solar and Mains Powered Vaccine Refrigerators and Freezers Industry Consultation 17 March 2022 Agenda 1. Introductions 2. 2021 Procurement 3. Spare parts Tender 4. Mains powered/SDDs Tender outcomes 5. Service bundle Tender Break 6. COVAX update 7. CCEOP update 8. AOB Thomas Jan Joyce Salima Lorena Tesfaye Gemma…

No matter where you come from, most people will agree, 2021 was a difficult year. For COVAX COVAX – the global vaccine equity mechanism – the year was marked by ground-breaking moments, great expectations and tremendous progress, coupled with unforeseen challenges and setbacks. But if there is one thing we can attest to, it’s that perseverance,…, Bumps along the road , UNICEF, as the lead delivery partner for COVAX, shipped 19 million vaccines to 45 countries during the first 20 days, including difficult to reach places from the Himalayas to remote Pacific islands and conflict zones. It was a time of great hope and we could collectively see a way out of the pandemic.   But soon after this promising start,…, Extraordinary collaboration , In June 2021, dose-sharing-how-global-solidarity-can-help-curb-pandemic UNICEF launched a major public campaign calling on well-supplied donor countries to share doses with others. As a result, more donated doses began to flow to COVAX. By February 2022, UNICEF delivered 500 million doses donated by 31 countries.  It’s not just donors that made a…, Delivering at scale, With vaccine supplies now steadily flowing in, we have turned a corner. COVAX delivered 1.2 billion vaccines to 144 countries within 12 months - an unprecedented effort. In December alone, due to the increased availability of supply, UNICEF delivered an all-time high of 340 million doses, which equates to the total quantities delivered during the…, The journey continues, As we look ahead into 2022, we are facing a radically altered picture compared to last year. Due to successful vaccine development, production scale up, and regulatory approvals, access to COVID-19 vaccines is no longer considered a bottleneck. However, demand for COVID-19 vaccines will vary from country to country based on national response plans…, Explore also:, One 24 February 2021, UNICEF began the international delivery of COVID-19 vaccines. One year on, UNICEF staff reflect on this milestone moment.

Please note that this dashboard will no longer be updated from January 2024 onwards and will remain online with archived data. We thank our partners and viewers for the feedback and collaboration that secured this dashboard utility for multiple users since the onset of the COVID-19 pandemic. The oxygen-related views are equally no longer updated…, More to explore

On 15 January 2022, a plane carrying 1.1 million COVID-19 vaccines, including the one billionth dose supplied through COVAX, touched down in Kigali, Rwanda.  COVAX has now delivered vaccines to 144 countries and territories, with 85 per cent of the doses shipped to 86 lower-income countries participating in the COVAX Advance Market Commitment (AMC…, Featured video, COVAX: 1 billion vaccines delivered

NEW YORK/COPENHAGEN, 18 January 2022 – UNICEF has signed several long term agreements (LTA) with suppliers for the procurement of the new antiviral medicine Molnupiravir.   UNICEF procurement of Molnupiravir is dependent on clinical recommendations, regulatory approvals and compliance with UNICEF quality assurance requirements. In December, the US…